The Company will provide further updates following communications with the FDA when additional information is available.

Type B Meeting Discussion to Accelerate XRx-026 for Gout to NDA CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Fra ...

Hyperuricemia (HU) is a metabolic disorder characterized by elevated uric acid (UA) levels in the bloodstream, commonly diagnosed when UA levels ...

广东省医疗援藏首席专家、广东省人民医院李欣教授，上海百趣代谢组学技术研究中心刘志鹏研究员和范艳群研究员为共同通讯作者；广东省人民医院陈轩馥博士后、邹国祥博士及杨智博博士为论文共同第一作者。

Zurampic is approved by the FDA for hyperuricemia associated with uncontrolled gout, in combination with a xanthine oxidase inhibitor (XOI). Duzallo is a combination of lesinurad and allopurinol ...